Skip to content

Enterprise Imaging XERO Viewer 8.1

by Agfa Healthcare N.V. FDA registration: Belgium EUDAMED510(k)

510(k) K170434 Product code LLZ

Overview

The Enterprise Imaging XERO Viewer 8.1 is a medical imaging software application designed for the viewing, analysis, and management of radiographic and other digital imaging studies. It provides radiologists and healthcare professionals with tools to interpret images, measure anatomical structures, and annotate findings within a clinical workflow.

This software is supplied as a digital product for use on compatible medical imaging workstations, requiring no physical sterilisation or single-use considerations. It is intended for use in radiology departments and imaging centres, adhering to FDA clearance under 510(k) and EU MDR compliance. The system operates within standard IT infrastructure and does not contain MRI-unsafe components, though its use is governed by institutional IT policies and imaging protocols.

Summary written by AI from registry data, 18 Sep 2026.Not verified

About this summary

This description and any FAQs on this page were generated automatically and have not been verified by the manufacturer or by deviCERTS. Always check the official registry entry and the manufacturer's instructions for use before relying on them.

Regulatory status

as of 26 Oct 2026

Recall ongoing. 2 ongoing FDA recalls. See recalls

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE 510(k) Substantially Equivalent · Traditional NumberK170434 Date3 Jul 2017ClearedStatusActive
European UnionCE/MDR EUDAMED Number— Date—StatusActive

Coverage

2 jurisdictions

United States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaSwedenFinlandFinlandUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaSwedenFinlandFinlandUnited States of AmericaUnited States of AmericaUnited States of AmericaSwedenSwedenLatviaEstoniaUnited States of AmericaDenmarkLithuaniaIrelandNetherlandsGermanyGermanyPolandPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaPolandUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaFranceFranceAustriaHungaryRomaniaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaFranceFranceSloveniaBulgariaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaPortugalSpainSpainItalyUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaSpainSpainCroatiaGreeceUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaMaltaCyprusUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not known
  • Not covered
  • European Union CE/MDR Active
  • United States FDA 510(k) Active

Certificates: none listed in EUDAMED

Recalls

2 recalls · 2 ongoing · FDA

    • Ongoing Z-0055-2025 FDA Class II initiated 6 Sep 2024

    Software defect, when an image has non-square pixel spacing, the reference/localizer line is incorrectly placed on the scout image in the XERO Viewet, may display the incorrect crosshair/line position on the non-coplanar/scout image with respect to the axial slice location. Inaccurate placement of reference lines or crosshairs have potential risk of misdiagnosis or mistreatment due to unintended shifts in the display of anatomical locations.

    • Ongoing Z-1004-2023 FDA Class II initiated 5 Dec 2022

    There is a software defect that can cause issues with images.

Specification

EUDAMED · 510(k) · synced 22 Oct 2026

510(k) Number
FDA Product Code
LLZ
Device Class
Class II
Regulation
21 CFR Part 892.2050
Advisory Committee
Radiology
FDA Decision
SESE Substantially Equivalent

Other devices from Agfa Healthcare N.V.

See all devices from Agfa Healthcare N.V. →

Questions

  • What types of medical images can the Enterprise Imaging XERO Viewer 8.1 analyze and display?

    The Enterprise Imaging XERO Viewer 8.1 is specifically designed to view, analyze, and manage radiographic and other digital imaging studies. This includes standard X-ray images, but it may also support other digital modalities depending on institutional integration, such as CT scans, MRIs (if the system is configured to handle them), and ultrasound images. The software provides tools for radiologists and healthcare professionals to interpret these images, measure anatomical structures, and annotate findings within a clinical workflow.

  • How is the Enterprise Imaging XERO Viewer 8.1 supplied, and does it require physical sterilization or single-use considerations?

    The Enterprise Imaging XERO Viewer 8.1 is supplied exclusively as a digital software application for installation on compatible medical imaging workstations. Since it is software-based, there are no physical components that require sterilization or single-use considerations. It operates entirely within standard IT infrastructure and does not involve any consumable or disposable materials.

  • Is the Enterprise Imaging XERO Viewer 8.1 compatible with MRI environments, and what safety considerations should be noted?

    The Enterprise Imaging XERO Viewer 8.1 does not contain any MRI-unsafe components, meaning it does not introduce electromagnetic interference or pose a risk in MRI environments. However, its use is governed by institutional IT policies and imaging protocols, so clinicians should confirm compatibility with their specific MRI systems and workflows before implementation. The software itself is not an MRI device but is designed to integrate with imaging systems used in radiology departments.

  • What regulatory pathways does the Enterprise Imaging XERO Viewer 8.1 follow in the U.S. and the EU?

    In the U.S., the Enterprise Imaging XERO Viewer 8.1 is cleared through the FDA’s 510(k) process, specifically under the Traditional clearance type with a decision code of SESE (Substantially Equivalent). This means it was determined to be substantially equivalent to a legally marketed predicate device. In the EU, it complies with the Medical Device Regulation (MDR), ensuring it meets the necessary safety, performance, and regulatory requirements for use within the European market.

  • What types of measurements and annotations can be performed using the Enterprise Imaging XERO Viewer 8.1?

    The software provides tools for radiologists and healthcare professionals to measure anatomical structures directly on digital images, which is useful for assessing dimensions, distances, or areas of interest. Additionally, it supports annotation features, allowing users to add notes, labels, or markings to findings within the images. These capabilities are integrated into the clinical workflow to enhance diagnostic accuracy and documentation.

Properties & raw data

Show properties, registry sources and raw records

Sources (2)

  • FDA 510(k) K170434 24 fields · synced 22 Oct 2026
  • EUDAMED 1 fields · synced 19 May 2026